Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

By B. Riggs, L. Hartmann. New England Journal of Medicine, 2003

916 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Pharmacology

View Paper: https://www.semanticscholar.org/paper/3d5a15670121c95875f1fa375da81d48a46f537c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Akram
2. M. Daniyal
3. Mehwish Iqbal
4. A. U. Khan

Citations in the corpus

• Awareness and current knowledge of breast cancer (2017, background): “Tamoxifen and raloxifene are selective estrogen receptor modulators (SERMs), a set of medicine that selectively prevents or motivates oestrogen-like activity in different tissues, affecting the estrogen receptors [184].”